Jan Lycke Free People Check 

( I'm Jan Lycke)

Loading...

Images of Jan Lycke

(0 from 0 )

News

(1 - 4 from 13
)

Alemtuzumab Reduces Disability From Relapsing-Remitting ...www.journalofclinicalpathways.com › news › alemtuzumab-reduces-disabil...

www.journalofclinicalpathways.com
Oct 21, · Dr. Jan Lycke from Sahlgrenska University Hospital's MS Center, Gothenburg, Sweden, told Reuters Health by email, "Alemtuzumab should be ...

History of Changes for Study: NCT ClinicalTrials.govclinicaltrials.gov › history › NCT

clinicaltrials.gov
Sponsor: Jan Lycke. Responsible Party: Sponsor-Investigator Investigator: Jan Lycke. Official Title: Professor. Affiliation: Sahlgrenska University Hospital ...

MS Matters: Diagnosis and monitoring in patients with MSwww.neurologybytes.com › events-cme › ms-webinar-diagnosis-and-monit...

www.neurologybytes.com
This interactive discussion, moderated by Professor Jan Lycke, will examine how the updated guidelines for diagnosis and monitoring are impacting the ...

Ny medicin förändrar livet för MS-sjuka | Hälsoliv | Expressen

www.expressen.se
GÖTEBORG. En ny revolutionerande bromsmedicin kan förändra livet för många MS-sjuka. Den tas i tablettform och minskar sjukdomsaktiviteten påtagligt. Jakob...
Save as document
+1